Home/ Supplements/ Omega 3/ Algal-900 DHA

Algal-900 DHA

product on market Softgel Capsule Spring Valley Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic acid (DHA) is an omega-3 fatty acid supported by strong evidence for promoting cognitive function and cardiovascular health. Research indicates it plays a critical role in maintaining the structural integrity of the brain and retina. Evidence coverage for this specific formulation is currently limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Algal-900 DHA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions Take one (1) softgel daily with a meal.

Warnings & Precautions

Important Information Safety Information Consult your health professional prior to use if you have or suspect a medical condition, are taking any prescription drugs or are pregnant or lactating.

Formulation Notes

450mg Algal DHA per softgel

This plant pure life's DHA contains no fish oil or fishy by-products, and is made in the USA via a unique, patented process.

Additional Information

VITAMIN #1 BRAND

SUPPORT BRAIN FUNCTION

Product Features - Dietary Supplement for the Brain and Heart. - Plant-Pure Omega-3

Prioduct Details - UPC: 681131312660

Product Description DHA Omega-3 represents about 97% of Omega-3's in the brain. DHA supports brain, heart and eye health.

Metadata

Product Details

UPC / SKU6 81131 31266 0
DSLD Entry Date2012-10-25
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID13039
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.